Pharmacogenomic Research in Korean Patients With Hepatitis C

A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1

NCT02170727 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis C

NCT02639585 ·Status: UNKNOWN ·Phase: PHASE4

Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.

NCT00422838 ·Status: COMPLETED

Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)

NCT01508156 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

NCT01056172 ·Status: UNKNOWN ·Phase: PHASE4

Prevalence of IL28B Polymorphism in Hepatitis C Patients

NCT03415009 ·Status: COMPLETED

HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China

NCT01293279 ·Status: COMPLETED

A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis

NCT01749150 ·Status: COMPLETED ·Phase: PHASE2

Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients

NCT00680173 ·Status: COMPLETED ·Phase: PHASE4

Postmarketing Surveillance of the Safety and Effectiveness of Daclatasvir and Asunaprevir for the Treatment of Chronic HCV Genotype 1B Infection in the Routine Clinical Practice in Korea

NCT02727933 ·Status: COMPLETED

Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)

NCT00828269 ·Status: COMPLETED ·Phase: PHASE1

Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C

NCT00980161 ·Status: UNKNOWN

Observational Study in HCV Chronic Infection

NCT01945008 ·Status: COMPLETED

Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection

NCT00164073 ·Status: UNKNOWN

Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C

NCT00322179 ·Status: COMPLETED

Factors Associated to Success of Hepatitis C Therapy

NCT00514111 ·Status: COMPLETED

Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood

NCT02718573 ·Status: COMPLETED

A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients

NCT00445315 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients

NCT01725529 ·Status: COMPLETED ·Phase: PHASE3

Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs

NCT02532907 ·Status: COMPLETED

A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection

NCT00157534 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis C

NCT01596517 ·Status: COMPLETED ·Phase: PHASE4

Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)

NCT03500562 ·Status: TERMINATED

Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir

NCT01577069 ·Status: COMPLETED

Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)

NCT05906459 ·Status: UNKNOWN